Literature DB >> 31102585

Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease.

Habib Haybar1, Mohammad Shokuhian2, Marziye Bagheri3, Nader Davari3, Najmaldin Saki4.   

Abstract

Cardiovascular disease (CVD) is an inflammatory disease that different factors play a crucial role in the development of clinical outcome of this disease. Inflammation could have effects on initiation, progression, and clinical complications of CVD. Previous studies have indicated that delineating the underlying mechanisms of inflammatory factors involved in this disease should be considerably beneficial both as predictive markers and targets for advancement of appropriate therapeutic approaches in offsetting development and progression of cardiovascular complications. Mechanisms of inflammatory factors involved in CVD combined with the development of atherosclerosis, reperfusion injury, and myocardial infarction caused by changes in processes such as endothelial cells function and hemostasis can contribute to the development of clinical outcome in CVD. Therefore, it can be stated that recognition of inflammatory mechanisms involved in this disease can be a promising tool for evaluation of prognosis in CVD patients. In this article, our goal is to evaluate the possible role of changes in the expressions of inflammatory factors in CVD as well as their relationship with prognosis of this disease.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular diseases; Diet; Inflammatory factors; Polymorphism; Prognosis

Mesh:

Substances:

Year:  2019        PMID: 31102585     DOI: 10.1016/j.yjmcc.2019.05.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  9 in total

1.  Comparative transcriptomic analysis of vascular endothelial cells after hypoxia/re-oxygenation induction based on microarray technology.

Authors:  Jia Xu; Jiu-Kun Jiang; Xiao-Lin Li; Xiao-Peng Yu; Ying-Ge Xu; Yuan-Qiang Lu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Apr.       Impact factor: 3.066

Review 2.  The role of age-associated autonomic dysfunction in inflammation and endothelial dysfunction.

Authors:  Yunqiu Jiang; Andriy Yabluchanskiy; Jielin Deng; Faris A Amil; Sunny S Po; Tarun W Dasari
Journal:  Geroscience       Date:  2022-06-30       Impact factor: 7.581

Review 3.  The gut microbiota and its interactions with cardiovascular disease.

Authors:  Hui Xu; Xiang Wang; Wenke Feng; Qi Liu; Shanshan Zhou; Quan Liu; Lu Cai
Journal:  Microb Biotechnol       Date:  2020-01-26       Impact factor: 5.813

Review 4.  Role of Endothelial Dysfunction in Cardiovascular Diseases: The Link Between Inflammation and Hydrogen Sulfide.

Authors:  Hai-Jian Sun; Zhi-Yuan Wu; Xiao-Wei Nie; Jin-Song Bian
Journal:  Front Pharmacol       Date:  2020-01-21       Impact factor: 5.810

Review 5.  IL-1β in atherosclerotic vascular calcification: From bench to bedside.

Authors:  Jialing Shen; Ming Zhao; Chunxiang Zhang; Xiaolei Sun
Journal:  Int J Biol Sci       Date:  2021-10-22       Impact factor: 6.580

6.  The role of peripheral blood eosinophil counts in acute Stanford type A aortic dissection patients.

Authors:  Xichun Qin; Yaxuan Gao; Yi Jiang; Feng Zhu; Wei Xie; Xinlong Tang; Yunxing Xue; Dongjin Wang; Hailong Cao
Journal:  Front Surg       Date:  2022-08-30

Review 7.  Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases.

Authors:  Alana Aragón-Herrera; Sandra Feijóo-Bandín; Laura Anido-Varela; Sandra Moraña-Fernández; Esther Roselló-Lletí; Manuel Portolés; Estefanía Tarazón; Oreste Gualillo; José Ramón González-Juanatey; Francisca Lago
Journal:  J Pers Med       Date:  2022-06-21

Review 8.  Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease.

Authors:  Yingdong Lu; Yang Zhang; Xin Zhao; Chang Shang; Mi Xiang; Li Li; Xiangning Cui
Journal:  Front Cardiovasc Med       Date:  2022-08-11

9.  Anti-Atherosclerotic Effect of Afrocyclamin A against Vascular Smooth Muscle Cells Is Mediated via p38 MAPK Signaling Pathway.

Authors:  Yan Gu; Z Hanzhan Xiao; Jianlie Wu; Mingjin Guo; Ping Lv; Ning Dou
Journal:  Cell J       Date:  2021-05-26       Impact factor: 2.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.